Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.verified

NBIX

Price:

$137.2

Market Cap:

$13.89B

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1996-05-23

Stock Exchange

NASDAQ

Ticker

NBIX

The Current Ratio as of December 2024 (TTM) for Neurocrine Biosciences, Inc. (NBIX) is 4.37

According to Neurocrine Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.37. This represents a change of 29.06% compared to the average of 3.38 of the last 4 quarters.

Neurocrine Biosciences, Inc. (NBIX) Historical Current Ratio (quarterly & annually)

How has NBIX Current Ratio performed in the past?

The mean historical Current Ratio of Neurocrine Biosciences, Inc. over the last ten years is 7.24. The current 4.37 Current Ratio has changed 5.93% with respect to the historical average. Over the past ten years (40 quarters), NBIX's Current Ratio was at its highest in in the March 2015 quarter at 26.66. The Current Ratio was at its lowest in in the December 2019 quarter at 1.47.

Quarterly (TTM)
Annual

Average

7.24

Median

6.91

Minimum

1.47

Maximum

14.94

Neurocrine Biosciences, Inc. (NBIX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Neurocrine Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 270.66%

Maximum Annual Current Ratio = 14.94

Minimum Annual Increase = -82.42%

Minimum Annual Current Ratio = 1.47

Quarterly (TTM)
Annual
YearCurrent RatioChange
20232.45-9.21%
20222.70-31.70%
20213.96-27.37%
20205.45270.66%
20191.47-82.42%
20188.36-17.99%
201710.20-0.11%
201610.21-31.66%
201514.9418.04%
201412.65-0.29%

Neurocrine Biosciences, Inc. (NBIX) Average Current Ratio

How has NBIX Current Ratio performed in the past?

The current Current Ratio of Neurocrine Biosciences, Inc. (NBIX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

3.04

5-year avg

3.21

10-year avg

7.24

Neurocrine Biosciences, Inc. (NBIX) Current Ratio vs. Peers

How is NBIX’s Current Ratio compared to its peers?

Neurocrine Biosciences, Inc.’s Current Ratio is greater than Amphastar Pharmaceuticals, Inc. (3.43), greater than Collegium Pharmaceutical, Inc. (0.97), greater than Ironwood Pharmaceuticals, Inc. (3.62), greater than ANI Pharmaceuticals, Inc. (2.74), greater than Deciphera Pharmaceuticals, Inc. (4.19), greater than Alkermes plc (3.45), greater than Avadel Pharmaceuticals plc (2.97), less than Intra-Cellular Therapies, Inc. (7.66), less than Dynavax Technologies Corporation (13.23), greater than Pacira BioSciences, Inc. (2.25), greater than Eagle Pharmaceuticals, Inc. (1.70), greater than Prestige Consumer Healthcare Inc. (3.56), greater than Evotec SE (2.09), greater than Supernus Pharmaceuticals, Inc. (2.20),

Build a custom stock screener for Neurocrine Biosciences, Inc. (NBIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurocrine Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurocrine Biosciences, Inc. (NBIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurocrine Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Neurocrine Biosciences, Inc.'s Current Ratio?

How is the Current Ratio calculated for Neurocrine Biosciences, Inc. (NBIX)?

What is the highest Current Ratio for Neurocrine Biosciences, Inc. (NBIX)?

What is the 3-year average Current Ratio for Neurocrine Biosciences, Inc. (NBIX)?

What is the 5-year average Current Ratio for Neurocrine Biosciences, Inc. (NBIX)?

How does the current Current Ratio for Neurocrine Biosciences, Inc. (NBIX) compare to its historical average?